Lineage Cell Therapeutics LCTX

$ 0.6 -7.07%

Quarterly report 2024-Q3
added 11-14-2024

Lineage Cell Therapeutics Total Liabilities 2011-2024 | LCTX

Annual Total Liabilities Lineage Cell Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
39 M	51.7 M	83.6 M	12.8 M	14.2 M	9.41 M	8.98 M	12.1 M	18.2 M	12.2 M	15.5 M	5.45 M	4.37 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
83.6 M	4.37 M	22.1 M

Quarterly Total Liabilities Lineage Cell Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
31.8 M	35.9 M	37.5 M	39 M	39.5 M	40.4 M	44.2 M	51.7 M	53.6 M	54.4 M	59.3 M	83.6 M	11.6 M	11.2 M	11.4 M	12.8 M	12.8 M	12.8 M	12.8 M	14.2 M	14.2 M	14.2 M	14.2 M	9.41 M	9.41 M	9.41 M	9.41 M	8.98 M	8.98 M	8.98 M	8.98 M	12.1 M	12.1 M	12.1 M	12.1 M	18.2 M	18.2 M	18.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
83.6 M	8.98 M	23.4 M